Cargando…
A Drosophila model of oral peptide therapeutics for adult intestinal stem cell tumors
Peptide therapeutics, unlike small-molecule drugs, display crucial advantages of target specificity and the ability to block large interacting interfaces, such as those of transcription factors. The transcription co-factor of the Hippo pathway, YAP/Yorkie (Yki), has been implicated in many cancers,...
Autores principales: | Bajpai, Anjali, Quazi, Taushif Ahmad, Tang, Hong-Wen, Manzar, Nishat, Singh, Virender, Thakur, Ashwani, Ateeq, Bushra, Perrimon, Norbert, Sinha, Pradip |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Company of Biologists Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390633/ https://www.ncbi.nlm.nih.gov/pubmed/32540914 http://dx.doi.org/10.1242/dmm.044420 |
Ejemplares similares
-
Human ERG oncoprotein represses a Drosophila LIM domain binding protein–coding gene Chip
por: Bharti, Mahima, et al.
Publicado: (2023) -
Dynamics of Cellular Plasticity in Prostate Cancer Progression
por: Tiwari, Ritika, et al.
Publicado: (2020) -
Selector genes display tumor cooperation and inhibition in Drosophila epithelium in a developmental context-dependent manner
por: Gupta, Ram Prakash, et al.
Publicado: (2017) -
Drosophila intestinal stem and progenitor cells are major sources and regulators of homeostatic niche signals
por: Doupé, David P., et al.
Publicado: (2018) -
Therapeutic implication of L-phenylalanine aggregation mechanism and its modulation by D-phenylalanine in phenylketonuria
por: Singh, Virender, et al.
Publicado: (2014)